NCT04166071View on ClinicalTrials.gov

Opioids and Social Support Enhanced Extinction Effects

EARLY_PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 13, 2021

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Fear
Interventions
DRUG

Naltrexone

Half of the participants will be randomly assigned to take one dose of naltrexone (50mg, capsule form) during the experimental session

DRUG

Placebo

Half of the participants will be randomly assigned to take a placebo capsule during the experimental session

Trial Locations (2)

90095

UCLA, Los Angeles

90095-1563

UCLA Department of Psychology, 5514 Pritzker Hall, Los Angeles

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of California, Los Angeles

OTHER